Page 4
www.cologuardtest.com | Rx Only
COLOGUARD WARNINGS AND PRECAUTIONS
The performance of Cologuard has been established in a cross-sectional
study (i.e., single point in time). Programmatic performance of Cologuard (i.e.,
benefits and risks with repeated testing over an established period of time)
has not been studied. Performance has not been evaluated in adults who
have been previously tested with Cologuard. Non-inferiority or superiority
of Cologuard programmatic sensitivity as compared to other recommended
screening methods for CRC and AA has not been established.
• The clinical validation study was conducted in patients 50 years of age and
older. ACS Guidelines recommend screening begin at age 45. Cologuard
performance in patients ages 45-49 was estimated by sub-group analysis of
near-age groups.
• CRC screening guideline recommendations vary for persons over the age
of 75. The decision to screen persons over the age of 75 should be made on
an individualized basis in consultation with a healthcare provider. Cologuard
test results should be interpreted with caution in older patients as the rate of
false positive results increases with age.
• A negative Cologuard test result does not guarantee absence of cancer or
advanced adenoma. Patients with a negative Cologuard test result should be
advised to continue participating in a colorectal cancer screening program
with another recommended screening method. The screening interval for
this follow-up has not been established.
• Cologuard may produce false negative or false positive results. A false positive
result occurs when Cologuard produces a positive result, even though a
colonoscopy will not find cancer or precancerous polyps. A false negative
result occurs when Cologuard does not detect a precancerous polyp or
colorectal cancer even when a colonoscopy identifies the positive result.
EN_LBL_10033_r7.indd 4 12/12/19 1:24 PM